ArticleJournal of the American College of Clinical Pharmacy : JACCP2022
Global resilience and new strategies needed for antimicrobial stewardship during the COVID-19 pandemic and beyond.
Article in Journal of the American College of Clinical Pharmacy : JACCP, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
10 citing papers in PubMed.
- UK Parliament's antimicrobial resistance inquiry: translating evidence into crisis-resilient action.JAC-antimicrobial resistance · 2025Review
- Laying the groundwork for an inter-ministerial One Health response to antimicrobial resistance in South Korea.One health (Amsterdam, Netherlands) · 2025Review
- Temporal Shifts in Pathogen Profiles Due to the COVID-19 Pandemic in a Romanian Pediatric Tertiary Hospital.Children (Basel, Switzerland) · 2025Article
- Time is running out. No excuses to delay implementation of antimicrobial stewardship programmes: impact, sustainability, resilience and efficiency through an interrupted time series analysis (2017-2022).JAC-antimicrobial resistance · 2024Article
- COVID-19 therapeutics: stewardship in England and considerations for antimicrobial resistance.The Journal of antimicrobial chemotherapy · 2023Article
- A qualitative interview study applying the COM-B model to explore how hospital-based trainers implement antimicrobial stewardship education and training in UK hospital-based care.BMC health services research · 2023Article
- A cross-sectional study of hospital antimicrobial stewardship programmes in the COVID-19 era.JAC-antimicrobial resistance · 2023Article
- Global collaborations in antimicrobial stewardship: All hands on deck.Antimicrobial stewardship & healthcare epidemiology : ASHE · 2023Article
- Global resilience and new strategies needed for antimicrobial stewardship during the COVID-19 pandemic and beyond.Journal of the American College of Clinical Pharmacy : JACCP · 2022Article
- Rising from the pandemic ashes: Reflections on burnout and resiliency from the infection prevention and antimicrobial stewardship workforce.Antimicrobial stewardship & healthcare epidemiology : ASHE · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
15 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Resilience is having the ability to respond to adversity proactively and resourcefully. The coronavirus disease 2019 (COVID-19) pandemic's profound impact on antimicrobial stewardship programs (ASP) requires clinicians to call on their own resilience to manage the demands of the pandemic and the disruption of ASP activities. This article provides examples of ASP resilience from pharmacists and physicians from seven countries with different resources and approaches to ASP-The United States, The United Kingdom, Canada, Nigeria, Lebanon, South Africa, and Colombia. The lessons learned pertain to providing ASP clinical services in the context of a global pandemic, developing new ASP paradigms in the face of COVID-19, leveraging technology to extend the reach of ASP, and conducting international collaborative ASP research remotely. This article serves as an example of how resilience and global collaboration is sustaining our ASPs by sharing new "how to" do antimicrobial stewardship practices during the COVID-19 pandemic.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.